Asthma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Asthma stocks.

Asthma Stocks Recent News

Date Stock Title
Jul 5 REGN Swing Trading Regeneron Stock Shows How To Bob And Weave
Jul 5 AZN AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Jul 5 AZN AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
Jul 5 AZN AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Jul 5 AZN Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Jul 5 AZN Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
Jul 5 REGN Dupixent “addresses current gap” in COPD biologics landscape
Jul 5 AZN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 TMO Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs
Jul 3 REGN Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3 REGN Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3 REGN Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Jul 2 REGN Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
Jul 2 TEVA Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
Jul 2 TEVA FTC investigates Teva over contested product patents
Jul 2 TMO Olink ticks higher amid Nasdaq notice on Thermo Fisher deal
Jul 2 AZN AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
Jul 2 REGN Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
Jul 2 TMO Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024
Asthma

Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. These episodes may occur a few times a day or a few times per week. Depending on the person, they may become worse at night or with exercise.Asthma is thought to be caused by a combination of genetic and environmental factors. Environmental factors include exposure to air pollution and allergens. Other potential triggers include medications such as aspirin and beta blockers. Diagnosis is usually based on the pattern of symptoms, response to therapy over time, and spirometry. Asthma is classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. It may also be classified as atopic or non-atopic, where atopy refers to a predisposition toward developing a type 1 hypersensitivity reaction.There is no cure for asthma. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or antileukotriene agents may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. Treatment of rapidly worsening symptoms is usually with an inhaled short-acting beta-2 agonist such as salbutamol and corticosteroids taken by mouth. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required.In 2015, 358 million people globally had asthma, up from 183 million in 1990. It caused about 397,100 deaths in 2015, most of which occurred in the developing world. It often begins in childhood. The rates of asthma have increased significantly since the 1960s. Asthma was recognized as early as Ancient Egypt. The word "asthma" is from the Greek ἅσθμα, ásthma, which means "panting".

Browse All Tags